OMSB Dermatology (OED) study materials
OMSB Dermatology (OED) study resources

Basal Cell Carcinoma of the Nasal Ala in an Anticoagulated Patient

OMSB Dermatology (OED) · Put your knowledge to work in context.

All case studies

Basal Cell Carcinoma of the Nasal Ala in an Anticoagulated Patient

A 68-year-old man with Fitzpatrick type II skin is referred for a 1.6 cm nodular lesion on the left nasal ala, present for 2 years and occasionally bleeding. A shave biopsy shows nodular basal cell carcinoma with no perineural invasion. The lesion involves the alar groove and extends to within 3 mm of the alar rim. He has no history of prior skin cancer or immunosuppression. His medications include apixaban 5 mg twice daily for atrial fibrillation and metoprolol. He is otherwise healthy and wants the best chance of cure with the least deformity. He asks whether Mohs surgery is necessary, how his blood thinner will be managed, and what reconstruction will involve.

1. Compare Mohs micrographic surgery with standard wide local excision for this lesion, including appropriate margins and the reasons for your recommendation.

Read the worked answer

This is a high-risk basal cell carcinoma because of its location in the nasal ala/alar groove (an H-zone aesthetic and functional unit), its size over 1 cm, and the need to preserve the alar rim.

Mohs micrographic surgery offers complete margin examination of the entire peripheral and deep edge, with tissue conservation. For a nodular basal cell carcinoma in this location, a 2–3 mm initial margin is typical, with additional stages taken as needed until clear. Mohs gives the highest cure rate for high-risk lesions and allows same-day reconstruction after confirmation of clear margins.

Standard wide local excision would require a larger clinical margin, often 4–6 mm for a high-risk basal cell carcinoma, and margin assessment is limited to representative sections. On the nasal ala, this increases the risk of an incomplete excision or an unnecessarily large defect and may compromise the alar rim.

Recommendation: Mohs surgery is preferred here because it maximizes cure while preserving the alar groove and rim. If Mohs is unavailable, standard excision with intraoperative frozen-section control and a plastic surgery consultation would be the next best option.

2. How should apixaban be managed perioperatively, and what intraoperative measures reduce bleeding?

Read the worked answer

Do not stop apixaban routinely for Mohs surgery. Continuing anticoagulation is generally safe for cutaneous surgery and avoids the thromboembolic risk of interruption. Bridging with low-molecular-weight heparin is not indicated for a procedure of this type and can increase bleeding. If the patient has additional risk factors, such as recent stroke or mechanical valve, coordinate with cardiology, but the default is to continue apixaban.

Intraoperative measures:

  • Use local anesthetic with epinephrine to reduce bleeding, with caution in the nasal ala because of vascular supply; inject slowly and avoid excessive volume.
  • Use good surgical technique: sharp dissection, precise electrocoagulation of small vessels, and pressure dressings.
  • Avoid excessive cautery near the alar rim to prevent cartilage injury and necrosis.
  • If bleeding is difficult, use a topical hemostatic agent and a layered closure or pressure dressing.

Postoperative counseling: Warn about oozing and bruising. Avoid NSAIDs and alcohol temporarily. Seek urgent care for expanding hematoma, severe pain, or signs of infection.

3. Describe the timing and options for reconstruction after Mohs, and outline the follow-up plan.

Read the worked answer

Timing: Reconstruct on the same day once frozen-section margins are clear. Delayed reconstruction is reserved for infected, heavily contaminated, or uncertain-margin defects. Same-day repair reduces patient anxiety and wound-care burden.

Options depend on defect size and depth:

  • A small superficial defect may heal by second intention, but this is less ideal on the alar rim because of scarring and notch deformity.
  • A bilobed flap or nasolabial transposition flap is useful for moderate alar defects, recruiting adjacent lax skin.
  • A full-thickness skin graft from the preauricular or supraclavicular area can be used for shallow defects, but color and texture match are inferior.
  • A composite graft may be needed if cartilage is exposed, though it has a higher failure rate.

Key principle: Avoid tension on the alar rim and preserve the nasal valve. A plastic surgery or oculoplastic consultation is reasonable for complex defects.

Follow-up: Review at 1–2 weeks for wound check, then every 6 months for 2 years, then annually. Counsel on sun protection and self-examination. Annual skin examination is appropriate given the history of keratinocyte carcinoma.